Meristem Family Wealth’s Thermo Fisher Scientific TMO Stock Holding History

Meristem Family Wealth’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$1.79M	Sell	3,034 -533	-15%	-$306K	0.19%	57
2021 Q4	$2.38M	Sell	3,567 -437	-11%	-$273K	0.2%	57
2021 Q3	$2.29M	Buy	4,004 +1,949	+95%	+$1.07M	0.22%	55
2021 Q2	$1.04M	Buy	2,055 +922	+81%	+$435K	0.16%	85
2021 Q1	$517K	Buy	1,133 +54	+5%	+$25.8K	0.1%	127
2020 Q4	$503K	Sell	1,079 -30	-3%	-$14.1K	0.11%	122
2020 Q3	$490K	Buy	1,109 +384	+53%	+$159K	0.13%	101
2020 Q2	$263K	Sell	725 -861	-54%	-$289K	0.07%	151
2020 Q1	$450K	Buy	+1,586	New	+$500K	0.14%	99

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Meristem Family Wealth's TMO Position: Q1 2022 in Review

Meristem Family Wealth reduced its Thermo Fisher Scientific (TMO) stake by 15% in Q1 2022, selling an estimated $306K and leaving 3,034 shares worth $1.79M. The position accounts for 0.19% of the portfolio, ranked #57.

Meristem Family Wealth first reported a position in TMO in Q1 2020 and has held it in 9 quarters since. The position peaked at $2.38M in Q4 2021. 2,315 funds tracked by Wall St. Rank hold TMO as of Q1 2022.

Meristem Family Wealth held 3,034 shares of Thermo Fisher Scientific worth $1.79M as of Q1 2022.
Meristem Family Wealth sold 533 Thermo Fisher Scientific shares in Q1 2022, an estimated $306K.
Thermo Fisher Scientific made up 0.19% of Meristem Family Wealth's portfolio in Q1 2022, its #57 holding.
Meristem Family Wealth first reported a position in Thermo Fisher Scientific in Q1 2020 and has held it in 9 quarters since.
Meristem Family Wealth's Thermo Fisher Scientific position peaked at $2.38M in Q4 2021.
2,315 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2022.

Based on Meristem Family Wealth's 13F filing for Q1 2022, filed 11 May 2022.